dc.contributor.author | Tahghighi, A | |
dc.contributor.author | Emami, S | |
dc.contributor.author | Razmi, S | |
dc.contributor.author | Marznaki, FR | |
dc.contributor.author | Ardestani, SK | |
dc.contributor.author | Dastmalchi, S | |
dc.contributor.author | Kobarfard, F | |
dc.contributor.author | Shafiee, A | |
dc.contributor.author | Foroumadi, A | |
dc.date.accessioned | 2018-08-26T07:57:49Z | |
dc.date.available | 2018-08-26T07:57:49Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49130 | |
dc.description.abstract | A novel series of 5-(5-nitrofuran-2-yl)-and 5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazole-2-amines bearing acyclic amine at C-2 position of thiadiazole ring were synthesized and evaluated in vitro against promastigote and amastigote forms of Leishmania major. The structure-activity of series was investigated by studying 40 compounds. The most active derivatives were hydroxypropylamino-and methoxypropylamino-analogs of 5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazole (compounds 29 and 32, respectively) with highest selectivity index (SI > 12). | |
dc.language.iso | English | |
dc.relation.ispartof | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | |
dc.subject | Antileishmanial activity | |
dc.subject | 5-nitrofuran | |
dc.subject | 5-nitrothiophene | |
dc.subject | 1,3,4-thiadiazole | |
dc.title | New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity | |
dc.type | Article | |
dc.citation.volume | 28 | |
dc.citation.issue | 4 | |
dc.citation.spage | 843 | |
dc.citation.epage | 852 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.3109/14756366.2012.689297 | |